Bioregenx (BRGX) Change in Accured Expenses (2023 - 2026)
Bioregenx (BRGX) recorded quarterly Change in Accured Expenses of $33718.0 in Q1 2026, down 37.29% quarter-over-quarter from $53771.0 in Q4 2025, and down 45.24% on a YoY basis from $61571.0 in Q1 2025.
Bioregenx (BRGX) Change in Accured Expenses (2023 - 2026) Analysis & Trends
Bioregenx's Change in Accured Expenses history runs 4 years deep, the most recent figure standing at $33718.0 for Q1 2026.
- In Q1 2026, Change in Accured Expenses fell 45.24% year-over-year to $33718.0; the TTM figure through Mar 2026 stood at -$46443.0 (down 128.67% YoY), while the FY2025 annual figure was -$18590.0, down 131.15% from the prior year.
- Change in Accured Expenses was $33718.0 for Q1 2026 at Bioregenx, down from $53771.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $112048.0 in Q2 2023 to a low of -$136984.0 in Q4 2023.
- Historically, Change in Accured Expenses has averaged $6303.3 across 4 years, with a median of $28440.0 in 2024.
- The sharpest annual moves came in 2024 and 2025: Change in Accured Expenses plunged 426.63% in 2024, then jumped 251.04% in 2025.
- A 4-year view of Change in Accured Expenses shows it stood at -$136984.0 in 2023, then soared by 126.58% to $36410.0 in 2024, then jumped by 47.68% to $53771.0 in 2025, then slumped by 37.29% to $33718.0 in 2026.
- The last three Change in Accured Expenses figures came in at $33718.0 (Q1 2026), $53771.0 (Q4 2025), and -$24896.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 8.92 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 11.03 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | -873,000.00 |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | -20.60 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | -6.14 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | -35.25 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | -9.67 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | 49.11 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | -10.77 Mn |
| 10 | Bioregenx | - | - | 348,288.00 | 33,718.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33,718.00 |
| Mar 31, 2026 | 33,718.00 |
| Dec 31, 2025 | 53,771.00 |
| Dec 31, 2025 | 53,771.00 |
| Sep 30, 2025 | -24,896.00 |
| Sep 30, 2025 | -24,896.00 |
| Jun 30, 2025 | -109,036.00 |
| Jun 30, 2025 | -109,036.00 |
| Mar 31, 2025 | 61,571.00 |
| Mar 31, 2025 | 61,571.00 |
| Dec 31, 2024 | 36,410.00 |
| Dec 31, 2024 | 36,410.00 |
| Sep 30, 2024 | 28,440.00 |
| Sep 30, 2024 | 28,440.00 |
| Jun 30, 2024 | 35,597.00 |
| Jun 30, 2024 | 35,597.00 |
| Mar 31, 2024 | -40,764.00 |
| Mar 31, 2024 | -40,764.00 |
| Dec 31, 2023 | -136,984.00 |
| Dec 31, 2023 | -136,984.00 |